THYSSENKRUPP NUCERA AG & CO (NCH2.DE) Stock Fundamental Analysis
Europe - FRA:NCH2 - DE000NCA0001 - Common Stock
8.275 EUR
-0.07 (-0.84%)
We assign a fundamental rating of 4 out of 10 to NCH2. NCH2 was compared to 43 industry peers in the Construction & Engineering industry. The financial health of NCH2 is average, but there are quite some concerns on its profitability. NCH2 shows excellent growth, but is valued quite expensive already.
1. Profitability
1.1 Basic Checks
In the past year NCH2 was profitable.
NCH2 had a positive operating cash flow in the past year.
Each year in the past 5 years NCH2 has been profitable.
The reported operating cash flow has been mixed in the past 5 years: NCH2 reported negative operating cash flow in multiple years.
1.2 Ratios
NCH2 has a Return On Assets of 1.09%. This is amonst the worse of the industry: NCH2 underperforms 81.40% of its industry peers.
NCH2 has a Return On Equity of 1.80%. This is amonst the worse of the industry: NCH2 underperforms 81.40% of its industry peers.
NCH2 has a worse Return On Invested Capital (0.08%) than 93.02% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.09% | ||
| ROE | 1.8% | ||
| ROIC | 0.08% |
ROA(3y)1.36%
ROA(5y)2.95%
ROE(3y)2.51%
ROE(5y)5.96%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
NCH2 has a worse Profit Margin (1.49%) than 79.07% of its industry peers.
NCH2's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 0.09%, NCH2 is not doing good in the industry: 93.02% of the companies in the same industry are doing better.
NCH2 has a Gross Margin of 11.22%. This is amonst the worse of the industry: NCH2 underperforms 86.05% of its industry peers.
NCH2's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 0.09% | ||
| PM (TTM) | 1.49% | ||
| GM | 11.22% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-42.36%
PM growth 5YN/A
GM growth 3Y-21.27%
GM growth 5YN/A
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NCH2 is destroying value.
The number of shares outstanding for NCH2 remains at a similar level compared to 1 year ago.
Compared to 1 year ago, NCH2 has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.80 indicates that NCH2 is not a great score, but indicates only limited risk for bankruptcy at the moment.
NCH2 has a better Altman-Z score (2.80) than 79.07% of its industry peers.
NCH2 has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
NCH2 has a better Debt to Equity ratio (0.03) than 97.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.8 |
ROIC/WACC0.01
WACC7.31%
2.3 Liquidity
NCH2 has a Current Ratio of 2.48. This indicates that NCH2 is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.48, NCH2 belongs to the top of the industry, outperforming 95.35% of the companies in the same industry.
NCH2 has a Quick Ratio of 2.04. This indicates that NCH2 is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of NCH2 (2.04) is better than 97.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.48 | ||
| Quick Ratio | 2.04 |
3. Growth
3.1 Past
NCH2 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 175.00%, which is quite impressive.
The earnings per share for NCH2 have been decreasing by -19.70% on average. This is quite bad
The Revenue has decreased by -4.88% in the past year.
NCH2 shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 39.21% yearly.
EPS 1Y (TTM)175%
EPS 3Y-19.7%
EPS 5YN/A
EPS Q2Q%-120%
Revenue 1Y (TTM)-4.88%
Revenue growth 3Y39.21%
Revenue growth 5YN/A
Sales Q2Q%-21.93%
3.2 Future
The Earnings Per Share is expected to grow by 60.71% on average over the next years. This is a very strong growth
NCH2 is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.19% yearly.
EPS Next Y-25.43%
EPS Next 2Y32%
EPS Next 3Y43.43%
EPS Next 5Y60.71%
Revenue Next Year2.77%
Revenue Next 2Y-6.02%
Revenue Next 3Y0.71%
Revenue Next 5Y12.19%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 75.23, which means the current valuation is very expensive for NCH2.
Based on the Price/Earnings ratio, NCH2 is valued a bit more expensive than the industry average as 79.07% of the companies are valued more cheaply.
When comparing the Price/Earnings ratio of NCH2 to the average of the S&P500 Index (25.56), we can say NCH2 is valued expensively.
NCH2 is valuated quite expensively with a Price/Forward Earnings ratio of 52.77.
Compared to the rest of the industry, the Price/Forward Earnings ratio of NCH2 indicates a rather expensive valuation: NCH2 more expensive than 81.40% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 34.62. NCH2 is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 75.23 | ||
| Fwd PE | 52.77 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NCH2 indicates a rather expensive valuation: NCH2 more expensive than 81.40% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 35.84 |
4.3 Compensation for Growth
NCH2's earnings are expected to grow with 43.43% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32%
EPS Next 3Y43.43%
5. Dividend
5.1 Amount
NCH2 does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:NCH2 (11/17/2025, 5:22:21 PM)
8.275
-0.07 (-0.84%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)
Earnings (Next)
Inst Owners16%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.05B
Revenue(TTM)912.00M
Net Income(TTM)13.60M
Analysts73.68
Price Target12.19 (47.31%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-9.09%
Min Revenue beat(2)-12.43%
Max Revenue beat(2)-5.74%
Revenue beat(4)1
Avg Revenue beat(4)-2.5%
Min Revenue beat(4)-12.43%
Max Revenue beat(4)10.74%
Revenue beat(8)1
Avg Revenue beat(8)-6.07%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-2.45%
EPS NQ rev (1m)0%
EPS NQ rev (3m)300%
EPS NY rev (1m)-17.57%
EPS NY rev (3m)28.49%
Revenue NQ rev (1m)-4.09%
Revenue NQ rev (3m)-4.33%
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)-1.2%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 75.23 | ||
| Fwd PE | 52.77 | ||
| P/S | 1.15 | ||
| P/FCF | N/A | ||
| P/OCF | 54.44 | ||
| P/B | 1.39 | ||
| P/tB | 1.53 | ||
| EV/EBITDA | 35.84 |
EPS(TTM)0.11
EY1.33%
EPS(NY)0.16
Fwd EY1.89%
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)0.15
OCFY1.84%
SpS7.22
BVpS5.97
TBVpS5.42
PEG (NY)N/A
PEG (5Y)N/A
Graham Number3.84
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.09% | ||
| ROE | 1.8% | ||
| ROCE | 0.1% | ||
| ROIC | 0.08% | ||
| ROICexc | 0.58% | ||
| ROICexgc | 1.54% | ||
| OM | 0.09% | ||
| PM (TTM) | 1.49% | ||
| GM | 11.22% | ||
| FCFM | N/A |
ROA(3y)1.36%
ROA(5y)2.95%
ROE(3y)2.51%
ROE(5y)5.96%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-42.36%
PM growth 5YN/A
GM growth 3Y-21.27%
GM growth 5YN/A
F-Score4
Asset Turnover0.73
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.03 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 2.31 | ||
| Cap/Depr | 261% | ||
| Cap/Sales | 2.86% | ||
| Interest Coverage | 1 | ||
| Cash Conversion | 177.78% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.48 | ||
| Quick Ratio | 2.04 | ||
| Altman-Z | 2.8 |
F-Score4
WACC7.31%
ROIC/WACC0.01
Cap/Depr(3y)106.05%
Cap/Depr(5y)76.37%
Cap/Sales(3y)0.81%
Cap/Sales(5y)0.64%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)175%
EPS 3Y-19.7%
EPS 5YN/A
EPS Q2Q%-120%
EPS Next Y-25.43%
EPS Next 2Y32%
EPS Next 3Y43.43%
EPS Next 5Y60.71%
Revenue 1Y (TTM)-4.88%
Revenue growth 3Y39.21%
Revenue growth 5YN/A
Sales Q2Q%-21.93%
Revenue Next Year2.77%
Revenue Next 2Y-6.02%
Revenue Next 3Y0.71%
Revenue Next 5Y12.19%
EBIT growth 1Y126.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year126.34%
EBIT Next 3Y56.43%
EBIT Next 5Y41.71%
FCF growth 1Y-341.18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-376.92%
OCF growth 3YN/A
OCF growth 5YN/A
THYSSENKRUPP NUCERA AG & CO / NCH2.DE FAQ
What is the fundamental rating for NCH2 stock?
ChartMill assigns a fundamental rating of 4 / 10 to NCH2.DE.
What is the valuation status of THYSSENKRUPP NUCERA AG & CO (NCH2.DE) stock?
ChartMill assigns a valuation rating of 1 / 10 to THYSSENKRUPP NUCERA AG & CO (NCH2.DE). This can be considered as Overvalued.
How profitable is THYSSENKRUPP NUCERA AG & CO (NCH2.DE) stock?
THYSSENKRUPP NUCERA AG & CO (NCH2.DE) has a profitability rating of 2 / 10.
What is the valuation of THYSSENKRUPP NUCERA AG & CO based on its PE and PB ratios?
The Price/Earnings (PE) ratio for THYSSENKRUPP NUCERA AG & CO (NCH2.DE) is 75.23 and the Price/Book (PB) ratio is 1.39.
What is the financial health of THYSSENKRUPP NUCERA AG & CO (NCH2.DE) stock?
The financial health rating of THYSSENKRUPP NUCERA AG & CO (NCH2.DE) is 6 / 10.